Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.170
-0.040 (-3.31%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Bionano Genomics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Bionano Genomics stock has a consensus rating of "Buy" and an average price target of $5.00. The average 1-year stock price forecast is 327.35% higher than the current stock price, while the lowest is $4.00 (+241.88%) and the highest is $6.00 (+412.82%).
Price Target: $5.00 (+327.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bionano Genomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $4 | Buy | Maintains | $4 | +241.88% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +412.82% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
32.14M
from 28.51M
Increased by 12.73%
Revenue Next Year
43.30M
from 32.14M
Increased by 34.74%
EPS This Year
-2.14
from -4.82
EPS Next Year
-0.97
from -2.14
EPS and Forward PE are based on non-GAAP adjusted numbers.